KLRD1 and cancer: In this sense, ligand–receptor interaction between CAFs and NK cells was reported to inhibit NK cell cytotoxicity toward cancer cells, downregulate the expression of activating NK cell receptors, and thereby promote cancer cell escape from NK cell surveillance, according to a study that used a mouse model of breast cancer.